Department of Justice Settles First False Claims Act Case Under its Civil Cyber-Fraud Initiative
Client Alert | 2 min read | 03.14.22
On March 8, 2022, the Department of Justice (“DOJ”) announced that Comprehensive Health Services LLC (“CHS”) agreed to pay $930,000 to resolve allegations that it violated the False Claims Act (“FCA”). DOJ alleges that CHS falsely represented to the State Department and Air Force that it complied with contract requirements relating to the secure storage of medical records under its contracts to provide medical services at government facilities overseas. CHS did not admit to liability in the settlement agreement.
CHS is a provider of medical solutions, including global medical services, that contracted with the State Department and Air Force to provide medical support services at government facilities in Iraq and Afghanistan. The FCA allegations stem from CHS’s purported failure to properly and securely store medical records containing “identifying information” and false representations regarding controlled substances provided under those government contracts. CHS submitted claims for the cost of a secure electronic medical record (“EMR”) system to store medical records, including the confidential identifying information of service members, officials, and contractors receiving medical care in Iraq. DOJ alleges that, between 2012 and 2019, CHS failed to disclose that staff would scan records into the EMR system and leave records on an internal network drive that was not secure and was accessible to non-clinical staff. CHS also failed to take adequate steps to store the information after staff raised concerns about the privacy of the identifying information.
DOJ also alleges that, between 2012 and 2019, CHS did not have the necessary Drug Enforcement Agency license to export controlled substances to Iraq, and falsely represented that unapproved substances provided under the contracts were approved by the Food and Drug Administration or European Medicines Agency.
The settlement resolves two cases brought under the whistleblower provisions of the FCA: United States ex rel. Lawler v. Comprehensive Health Servs., Inc. et al., Case No. 20-cv-698 (E.D.N.Y.), and United States ex rel. Watkins et al. v. CHS Middle East, LLC, Case No. 17-cv-4319 (E.D.N.Y.). Under the terms of the settlement agreement, CHS will also pay more than $500,000 in attorney’s fees to the relators.
This is the first FCA settlement under the DOJ’s Civil Cyber-Fraud Initiative and will certainly not be the last. As we previously predicted, we expect DOJ’s announcement of the initiative five months ago to lead to an uptick in FCA investigations, settlements, and litigation concerning cybersecurity issues and increased interest by those in the relator’s bar for qui tam actions. Notably, this settlement suggests that DOJ will not limit its enforcement actions to a contractor’s failure to satisfy its obligations under the standard Federal Acquisition Regulation or Defense Federal Acquisition Regulations safeguarding clauses, but will broadly consider noncompliance with other information and data security provisions to be an appropriate hook for FCA liability.
Contacts

Partner and Crowell Global Advisors Senior Director
- Washington, D.C.
- D | +1.202.624.2698
- Washington, D.C. (CGA)
- D | +1 202.624.2500
Insights
Client Alert | 7 min read | 11.05.26
2026 State Attorney General Elections: What Businesses Should Expect
As of November 4, 2026, the state attorney general elections point to increased enforcement in 2027, particularly in consumer protection, antitrust, AI, health care, and data centers.[1] Businesses should prepare for more investigations under existing laws and proposals for new legislation or rules. Campaign commitments indicate priorities, but their timing and implementation remain uncertain.[2]
Client Alert | 3 min read | 11.05.26
Federal, State, and Local Regulators Sue Toast Over B2B Advertising and Subscriptions
Client Alert | 3 min read | 11.04.26
CMS Proposal Would Overhaul Eligibility Rules for ACA Exchanges
Client Alert | 7 min read | 11.04.26
FDA Issues Guidance on Prescription Drug Use-Related Software



